PFE vs BIIB — Key Metrics
| Metric | PFE (PFIZER INC) | BIIB (BIOGEN INC) |
|---|---|---|
| Price | 28.52 | 225.88 |
| Market Cap | 162.55 Billion | 33.37 Billion |
| P/E (TTM) | 37.53 | 39.77 |
| P/B (Quarterly) | 1.7 | 1.64 |
| P/S (TTM) | 2.55 | 3.33 |
| Net Profit Margin (TTM) | 6.8 | 8.3 |
| Gross Margin (TTM) | 73.2 | 74.0 |
| ROE (TTM) | 4.9 | 4.5 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
PFE · PFIZER INC
Greatly Outperform
BIIB · BIOGEN INC
Outperform
Recommendation Summary
Stock PFE is projected to greatly outperform the market, stock BIIB is projected to outperform the market. Upfront Recommendation: PFE.
Financial Metrics
Prices delayed ~15 min
| PFE | Metrics | BIIB |
|---|---|---|
| $28.52 | Price | $225.88 |
| — | Market Capitalization | — |
| 37.53 | Price to Earnings Ratio | 39.77 |
| 2.55 | Price to Sales | 3.33 |
| 14.8 | Price to FCF Ratio | 12.48 |
| 3.49 | Price to Gross Profit | 4.5 |
| 14.71 | Price to R&D | 16.57 |
| 3.93 | Price to Current Assets | 4.57 |